Galderma Launches Sculptra in China
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.